Redbud exhibits at Next Gen Dx Summit and Dr. Spero presents in the POCT & ID program

Aug 6, 2019 | Events, Past Events

Redbud Labs will showcase products at the exposition during the 2019 Next Gen Dx Summit held in Washington D.C. at the Grand Hyatt hotel August 20 – 22 (Booth #309).  Additionally, Richard Spero, Ph.D. and CEO of Redbud, will be taking part in the POCT & Infectious Disease program. Dr. Spero will present a panel presentation talk entitled Breaking Through the Sample Prep Bottleneck in the Enabling Point-of-Care Diagnostics- Applications of Rapid Laboratory Diagnostics Point-of-Care panel discussion at 12:15 p.m. (held in the Constitution A Ballroom). Also, and on Wednesday at 6:45 p.m. as part of the program’s Emerging Technologies at the Point-of-Care section, Dr. Spero will co-present the Microfluidics and Lab-on-a-Chip Devices for POCT: Technologies and Commercialization short course taught by Chris Myatt, Founder & CEO MBio Diagnostics, Inc.

Offices, Production, and Labs
400 Park Offices Dr. #301
RTP NC 27709

Mail
PO Box 13195
RTP NC 27709

About Us
Redbud Labs, headquartered in Research Triangle Park, North Carolina, manufacturers breakthrough components for life science industry, intended to solve the industry’s ubiquitous microscale fluidic challenges.

Connect With Us

14 + 6 =

Connect With Us

5 + 8 =